Genmab Market Cap

Genmab has a market cap or net worth of 103.75 billion as of April 28, 2026. Its market cap has increased by 33.39% in one year.

Market Cap

103.75B

Enterprise Value

127.36B

Revenue

23.66B

Ranking

n/a

PE Ratio

17.29

Stock Price

1,690.00

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 103.75B, an increase of 2,716.10%. That is a compound annual growth rate of 13.96%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	103.75B	-16.91%
Dec 30, 2025	124.86B	31.70%
Dec 30, 2024	94.81B	-32.65%
Dec 29, 2023	140.77B	-26.77%
Dec 30, 2022	192.23B	11.72%
Dec 30, 2021	172.06B	6.80%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Novo Nordisk	1,153.29B
Coloplast	93.02B
ALK-Abelló	50.03B
Demant	43.28B
H. Lundbeck	42.17B
Zealand Pharma	21.42B
Ambu A/S	17.24B
Bavarian Nordic	14.36B

Market Cap Rankings